Compounds > vidarabine
Page last updated: 2024-08-22

vidarabine and adefovir

vidarabine has been researched along with adefovir in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Davari, H; Hakimelahi, GH; Hakimelahi, S; Jain, ML; Ly, TW; Mei, HC; Moosavi-Movahedi, AA; Moshfegh, AA; Sambaiah, T; Zakerinia, M1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Boyer, SH; Colby, TJ; Erion, MD; Gomez-Galeno, J; Lemus, RH; Matelich, MC; Reddy, KR; Schanzer, J; Ugarkar, BG; Van Poelje, PD1

Other Studies

3 other study(ies) available for vidarabine and adefovir

ArticleYear
Design, synthesis, and biological evaluation of novel nucleoside and nucleotide analogues as agents against DNA viruses and/or retroviruses.
    Journal of medicinal chemistry, 2001, Oct-25, Volume: 44, Issue:22

    Topics: Adenine; Adenine Nucleotides; Adenosine Deaminase Inhibitors; Animals; Antineoplastic Agents; Antiviral Agents; Cell Line; Chlorocebus aethiops; DNA Viruses; Drug Design; Enzyme Inhibitors; Lethal Dose 50; Leukemia, Experimental; Mice; Nucleosides; Nucleotides; Phosphoric Diester Hydrolases; Phosphorylation; Retroviridae; Retroviridae Infections; Simplexvirus; Snake Venoms; Spleen; Thymidine Kinase; Tumor Virus Infections; Vero Cells

2001
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Design, synthesis, and characterization of a series of cytochrome P(450) 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phosph(on)ate-based drugs to the liver.
    Journal of the American Chemical Society, 2004, Apr-28, Volume: 126, Issue:16

    Topics: Adenine; Animals; Catalysis; Cytarabine; Cytochrome P-450 Enzyme System; Drug Delivery Systems; Drug Design; Hepatocytes; Humans; Liver; Male; Organophosphonates; Phosphates; Phosphotransferases; Prodrugs; Rats; Stereoisomerism; Time Factors; Vidarabine

2004